Article info

Download PDFPDF
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients
  1. Correspondence to:
    Professor Allan D Struthers
    Division of Medicine & Therapeutics, Ninewells Hospital, Dundee DD1 9SY, UK; a.d.struthers{at}dundee.ac.uk
View Full Text

Citation

Struthers AD
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients

Publication history

  • Accepted November 16, 2005
  • First published December 9, 2005.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.